Matthew R Lammi1,2, Lesley Ann Saketkoo2,3, Samuel C Okpechi4,5, Mohamed A Ghonim4,6, Dorota Wyczechowska4, Natalie Bauer7, Kusma Pyakurel4, Saito Saito2,3, Bennett P deBoisblanc1,2, A Hamid Boulares4. 1. Section of Pulmonary/Critical Care and Allergy Immunology, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 2. Comprehensive Pulmonary Hypertension Center-University Medical Center, New Orleans, LA, USA. 3. Tulane University School of Medicine, New Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, USA. 4. Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 5. Biochemistry and Molecular Biology, School of Graduate Studies, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 6. Department of Microbiology and Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. 7. Department of Pharmacology and Center For Lung Biology, University of South Alabama, Mobile, AL, USA.
Abstract
BACKGROUND AND OBJECTIVE: Endothelial microparticles (EMP) are submicron vesicles released from endothelial cells. We aimed to determine the utility of EMP as biomarkers of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) patients and the pathogenic role of microparticles (MP) in vascular inflammation. METHODS: Levels of EMP (CD144+, CD31+, CD62E+ and CD143+) were compared between three groups (10 SSc patients with PAH, 10 SSc patients without pulmonary hypertension (no-PH) and 10 healthy age- and sex-matched controls). Human pulmonary artery endothelial cells (HPAEC) were exposed in vitro to MP obtained from SSc patients or healthy controls, and levels of cytokines and inflammatory adhesion molecules were compared. RESULTS: CD144+ EMP were significantly higher in the SSc-PAH group compared to either the SSc-no PH or healthy controls (diagnostic accuracy 80%, P = 0.02). Compared to controls, SSc patients had higher CD31+/CD62E+ ratios, indicating larger contributions of apoptosis to EMP release (P = 0.04). Patients with limited SSc had significantly higher levels of CD143+ EMP compared to those with diffuse subtype (P = 0.008). When HPAEC were exposed to MP from SSc patients, there was a significant increase in inflammatory cytokines and adhesion molecules. Interestingly, exposure to healthy control MP caused a reduction in inflammatory markers. CONCLUSION: EMP (particularly CD144+) are promising biomarkers of PAH in SSc but require further study. MP isolated from SSc patients induced an increase in endothelial cell inflammation and may be an important pathogenic factor in SSc.
BACKGROUND AND OBJECTIVE: Endothelial microparticles (EMP) are submicron vesicles released from endothelial cells. We aimed to determine the utility of EMP as biomarkers of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) patients and the pathogenic role of microparticles (MP) in vascular inflammation. METHODS: Levels of EMP (CD144+, CD31+, CD62E+ and CD143+) were compared between three groups (10 SSc patients with PAH, 10 SSc patients without pulmonary hypertension (no-PH) and 10 healthy age- and sex-matched controls). Human pulmonary artery endothelial cells (HPAEC) were exposed in vitro to MP obtained from SSc patients or healthy controls, and levels of cytokines and inflammatory adhesion molecules were compared. RESULTS:CD144+ EMP were significantly higher in the SSc-PAH group compared to either the SSc-no PH or healthy controls (diagnostic accuracy 80%, P = 0.02). Compared to controls, SSc patients had higher CD31+/CD62E+ ratios, indicating larger contributions of apoptosis to EMP release (P = 0.04). Patients with limited SSc had significantly higher levels of CD143+ EMP compared to those with diffuse subtype (P = 0.008). When HPAEC were exposed to MP from SSc patients, there was a significant increase in inflammatory cytokines and adhesion molecules. Interestingly, exposure to healthy control MP caused a reduction in inflammatory markers. CONCLUSION: EMP (particularly CD144+) are promising biomarkers of PAH in SSc but require further study. MP isolated from SSc patients induced an increase in endothelial cell inflammation and may be an important pathogenic factor in SSc.
Authors: Joaquin J Jimenez; Wenche Jy; Lucia M Mauro; Carl Soderland; Lawrence L Horstman; Yeon S Ahn Journal: Thromb Res Date: 2003-02-15 Impact factor: 3.944
Authors: Christian Jung; Karl Drummer; Peter Oelzner; Hans R Figulla; Joachim Boettcher; Marcus Franz; Stefan Betge; Martin Foerster; Gunter Wolf; Alexander Pfeil Journal: Clin Hemorheol Microcirc Date: 2015 Impact factor: 2.375
Authors: D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan Journal: Ann Rheum Dis Date: 2003-11 Impact factor: 19.103
Authors: Veronica Codullo; Helen M Baldwin; Mark D Singh; Alasdair R Fraser; Catherine Wilson; Ashley Gilmour; Axel J Hueber; Claudia Bonino; Iain B McInnes; Carlomaurizio Montecucco; Gerard J Graham Journal: Ann Rheum Dis Date: 2011-02-01 Impact factor: 19.103
Authors: Mohamed A Ghonim; Kusma Pyakurel; Salome V Ibba; Amir A Al-Khami; Jeffrey Wang; Paulo Rodriguez; Hamada F Rady; Ali H El-Bahrawy; Matthew R Lammi; Moselhy S Mansy; Kamel Al-Ghareeb; Alistair Ramsay; Augusto Ochoa; Amarjit S Naura; A Hamid Boulares Journal: J Transl Med Date: 2015-07-14 Impact factor: 5.531
Authors: J Gerry Coghlan; Christopher P Denton; Ekkehard Grünig; Diana Bonderman; Oliver Distler; Dinesh Khanna; Ulf Müller-Ladner; Janet E Pope; Madelon C Vonk; Martin Doelberg; Harbajan Chadha-Boreham; Harald Heinzl; Daniel M Rosenberg; Vallerie V McLaughlin; James R Seibold Journal: Ann Rheum Dis Date: 2013-05-18 Impact factor: 19.103
Authors: Lesley Ann Saketkoo; Tracy Frech; Cecília Varjú; Robyn Domsic; Jessica Farrell; Jessica K Gordon; Carina Mihai; Nora Sandorfi; Lee Shapiro; Janet Poole; Elizabeth R Volkmann; Monika Lammi; Kendra McAnally; Helene Alexanderson; Henrik Pettersson; Faye Hant; Masataka Kuwana; Ami A Shah; Vanessa Smith; Vivien Hsu; Otylia Kowal-Bielecka; Shervin Assassi; Maurizio Cutolo; Cristiane Kayser; Victoria K Shanmugam; Madelon C Vonk; Kim Fligelstone; Nancy Baldwin; Kerri Connolly; Anneliese Ronnow; Beata Toth; Maureen Suave; Sue Farrington; Elana J Bernstein; Leslie J Crofford; László Czirják; Kelly Jensen; Monique Hinchclif; Marie Hudson; Matthew R Lammi; Jennifer Mansour; Nadia D Morgan; Fabian Mendoza; Mandana Nikpour; John Pauling; Gabriela Riemekasten; Anne-Marie Russell; Mary Beth Scholand; Elise Seigart; Tatiana Sofia Rodriguez-Reyna; Laura Hummers; Ulrich Walker; Virginia Steen Journal: Best Pract Res Clin Rheumatol Date: 2021-09-15 Impact factor: 4.991